How Do Private Providers Unaffiliated With the Nigeria National TB Program Diagnose and Treat Drug-Susceptible TB Patients? A Cross-Sectional Study

Figures & Tables

TABLE 1.

Demographic Characteristics of Non-NTP Providers, Lagos, Nigeria

Provider Characteristics	Providers, No. (%) (N=152)=
Age, years
20–34	56 (36.8)
35–49	46 (30.3)
50–64	40 (26.3)
>65	10 (6.6)
Gender
Female	89 (58.6)
Male	63 (41.4)
Type of health facility
Private not-for-profit	13 (8.6)
Private for-profit	139 (91.4)
Monthly outpatient department patients treated
<100	57 (37.5)
100–200	46 (30.3)
200–500	33 (21.7)
>500	16 (10.5)
Qualification
MBBS/General practitioner	60 (39.5)
Nurse/Midwife	92 (60.5)
Time in clinical practice, years
1–16	73 (53.3)
17–44	64 (46.7)
Previously managed TB patient
No	61 (40.1)
Yes	91 (59.9)
Prior participation in TB-specific training
No	106 (69.7)
Yes	46 (30.3)
Time since last TB training, years
<1	9 (19.6)
1–5	18 (39.1)
5–10	14 (30.4)
>10	5 (10.9)

Abbreviations: MBBS, Bachelor of Medicine and Bachelor of Surgery; NTP, National TB Program.

TABLE 2.

Prescription Practices for Anti-TB Drug Regimen Among Non-NTP Providers, Lagos, Nigeria

Anti-TB Drug Regimen	Providers, No. (%) (N=108)
Regimen recommended by NTP
Rifampicin, isoniazid, pyrazinamide, and ethambutol	35 (32.4)
Regimen(s) not recommended by NTP
Isoniazid and rifampicin	11 (10.2)
Ethambutol, isoniazid, and rifampicin	10 (9.3)
Isoniazid, rifampicin, and streptomycin	10 (9.3)
Isoniazid	6 (5.6)
Ethambutol, isoniazid, and pyrazinamide	4 (3.7)
Isoniazid, pyrazinamide, rifampicin, and streptomycin	4 (3.7)
Rifampicin, isoniazid, pyrazinamide, ethambutol, and pyridoxine	4 (3.7)
Rifampicin and streptomycin	4 (3.7)
Isoniazid, pyrazinamide, and rifampicin	3 (2.8)
Ethambutol, pyrazinamide, and rifampicin	2 (1.9)
Ethambutol and rifampicin	2 (1.9)
Isoniazid and pyridoxine	2 (1.9)
Streptomycin injection	2 (1.9)
Cefritriaxone, gentamycin, rifampicin, and streptomycin	1 (0.9)
Cotrmoxazole and ethambutol	1 (0.9)
Ethambutol and isoniazid	1 (0.9)
Ethambutol, isoniazid, pyridoxine, and rifampicin	1 (0.9)
Ethambutol, isoniazid, rifampicin, and streptomycin	1 (0.9)
Ethambutol, isoniazid, rifampicin, and thiacetazone	1 (0.9)
Ethambutol, pyrazinamide, and streptomycin	1 (0.9)
Isoniazid, pyridoxine, and rifampicin	1 (0.9)
Rifampicin, isoniazid, pyrazinamide, and pyridoxine	1 (0.9)
Total	108 (100)

TABLE 4.

Type of TB Diagnostic Test Ordered by Non-NTP Providers, Lagos, Nigeria